Loading company details...
Beta
Latest Form 4 (Oct 5, 2026): Christophe Arbet-Engels (Chief Medical Officer): Exercise/Conversion of 37,500 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Christophe Arbet-Engels, Chief Medical Officer | Exercise/Conversion | 37,500 | n/a |
| Oct 5, 2026 | Gregory L. Weaver, Chief Financial Officer | Exercise/Conversion | 14,475 | n/a |
| Oct 2, 2026 | Richard Thomas Menziuso, Principal Accounting Officer | Grant/Award | 84,546 | n/a |
| Sep 17, 2026 | Linda M. Richardson, Chief Commercial Officer | Exercise/Conversion | 24,000 | n/a |
| Aug 13, 2026 | Jerome Benedict Durso, President and CEO | Purchase | 15,000 | $44.3K |
| Aug 3, 2026 | Gregory L. Weaver, Chief Financial Officer | Grant/Award | 1,753 | $4.2K |
| Aug 3, 2026 | M. Scot Roberts, Chief Scientific Officer | Grant/Award | 875 | $2.1K |
| May 1, 2026 | Teri L. Lawver | Grant/Award | 48,800 | n/a |
| May 1, 2026 | Catherine A. Sohn | Grant/Award | 48,800 | n/a |
| May 1, 2026 | Diane Jorkasky | Grant/Award | 48,800 | n/a |